Literature DB >> 21441775

The peptide network regulated by angiotensin converting enzyme (ACE) in hematopoiesis.

Xiao Z Shen1, Kenneth E Bernstein.   

Abstract

The concept of a local bone marrow renin-angiotensin system (RAS) has been introduced and accumulating evidence suggests that the local RAS is actively involved in hematopoiesis. Angiotensin converting enzyme (ACE) is a key player in the RAS and makes the final effector angiotensin II. Besides angiotensin II, ACE also regulates a panel of bioactive peptides, such as substance P, Ac-SDKP and angiotensin 1-7. These peptides have also been individually reported in the regulation of pathways of hematopoiesis. In this setting, an ACE-regulated peptide network orchestrating hematopoiesis has emerged. Here, we focus on this peptide network and discuss the roles of ACE and its peptides in aspects of hematopoiesis. Special attention is given to the recent revelation that ACE is a bona fide marker of hematopoietic stem cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21441775      PMCID: PMC3117040          DOI: 10.4161/cc.10.9.15444

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  77 in total

Review 1.  The significance of substance P in physiological and malignant haematopoiesis.

Authors:  Michal Nowicki; Danuta Ostalska-Nowicka; Beata Kondraciuk; Bogdan Miskowiak
Journal:  J Clin Pathol       Date:  2006-12-15       Impact factor: 3.411

2.  Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure.

Authors:  M Lenfant; J Wdzieczak-Bakala; E Guittet; J C Prome; D Sotty; E Frindel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  Bone marrow endothelial cells secrete thymosin beta4 and AcSDKP.

Authors:  W Q Huang; Q R Wang
Journal:  Exp Hematol       Date:  2001-01       Impact factor: 3.084

4.  G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor.

Authors:  Evi Kostenis; Graeme Milligan; Arthur Christopoulos; Carlos F Sanchez-Ferrer; Silvia Heringer-Walther; Patrick M Sexton; Florian Gembardt; Elaine Kellett; Lene Martini; Patrick Vanderheyden; Heinz-Peter Schultheiss; Thomas Walther
Journal:  Circulation       Date:  2005-04-04       Impact factor: 29.690

Review 5.  Different in vivo functions of the two catalytic domains of angiotensin-converting enzyme (ACE).

Authors:  Kenneth E Bernstein; Xiao Z Shen; Romer A Gonzalez-Villalobos; Sandrine Billet; Derick Okwan-Duodu; Frank S Ong; Sebastien Fuchs
Journal:  Curr Opin Pharmacol       Date:  2010-12-02       Impact factor: 5.547

6.  Direct and reversible inhibitory effect of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (Seraspenide) on the growth of human CD34+ subpopulations in response to growth factors.

Authors:  D Bonnet; F M Lemoine; S Pontvert-Delucq; C Baillou; A Najman; M Guigon
Journal:  Blood       Date:  1993-12-01       Impact factor: 22.113

7.  Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity.

Authors:  Michael Platten; Sawsan Youssef; Eun Mi Hur; Peggy P Ho; May H Han; Tobias V Lanz; Lori K Phillips; Matthew J Goldstein; Roopa Bhat; Cedric S Raine; Raymond A Sobel; Lawrence Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-19       Impact factor: 11.205

8.  Involvement of human plasma angiotensin I-converting enzyme in the degradation of the haemoregulatory peptide N-acetyl-seryl-aspartyl-lysyl-proline.

Authors:  K J Rieger; N Saez-Servent; M P Papet; J Wdzieczak-Bakala; J L Morgat; J Thierry; W Voelter; M Lenfant
Journal:  Biochem J       Date:  1993-12-01       Impact factor: 3.857

9.  Role of the N-terminal catalytic domain of angiotensin-converting enzyme investigated by targeted inactivation in mice.

Authors:  Sebastien Fuchs; Hong D Xiao; Justin M Cole; Jonathan W Adams; Kristen Frenzel; Annie Michaud; Hui Zhao; George Keshelava; Mario R Capecchi; Pierre Corvol; Kenneth E Bernstein
Journal:  J Biol Chem       Date:  2004-02-02       Impact factor: 5.157

10.  Converting enzyme determines plasma clearance of angiotensin-(1-7).

Authors:  K Yamada; S N Iyer; M C Chappell; D Ganten; C M Ferrario
Journal:  Hypertension       Date:  1998-09       Impact factor: 10.190

View more
  13 in total

Review 1.  Nontraditional roles of angiotensin-converting enzyme.

Authors:  Xiao Z Shen; Frank S Ong; Ellen A Bernstein; Tea Janjulia; Wendell-Lamar B Blackwell; Kandarp H Shah; Brian L Taylor; Romer A Gonzalez-Villalobos; Sebastien Fuchs; Kenneth E Bernstein
Journal:  Hypertension       Date:  2012-02-21       Impact factor: 10.190

Review 2.  Pathobiological Interactions of Local Bone Marrow Renin-Angiotensin System and Central Nervous System in Systemic Arterial Hypertension.

Authors:  Rafiye Ciftciler; Ibrahim Celalettin Haznedaroglu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-07       Impact factor: 5.555

3.  Delayed Captopril Administration Mitigates Hematopoietic Injury in a Murine Model of Total Body Irradiation.

Authors:  Elizabeth A McCart; Young H Lee; Jyoti Jha; Ognoon Mungunsukh; W Bradley Rittase; Thomas A Summers; Jeannie Muir; Regina M Day
Journal:  Sci Rep       Date:  2019-02-18       Impact factor: 4.379

Review 4.  Therapeutic Targeting of Cancer Stem Cells via Modulation of the Renin-Angiotensin System.

Authors:  Imogen M Roth; Agadha C Wickremesekera; Susrutha K Wickremesekera; Paul F Davis; Swee T Tan
Journal:  Front Oncol       Date:  2019-08-08       Impact factor: 6.244

5.  Loss of Angiotensin-Converting Enzyme 2 Exacerbates Diabetic Retinopathy by Promoting Bone Marrow Dysfunction.

Authors:  Yaqian Duan; Eleni Beli; Sergio Li Calzi; Judith L Quigley; Rehae C Miller; Leni Moldovan; Dongni Feng; Tatiana E Salazar; Sugata Hazra; Jude Al-Sabah; Kakarla V Chalam; Thao Le Phuong Trinh; Marya Meroueh; Troy A Markel; Matthew C Murray; Ruchi J Vyas; Michael E Boulton; Patricia Parsons-Wingerter; Gavin Y Oudit; Alexander G Obukhov; Maria B Grant
Journal:  Stem Cells       Date:  2018-07-15       Impact factor: 6.277

Review 6.  Answering the ultimate question "what is the proximal cause of aging?".

Authors:  Mikhail V Blagosklonny
Journal:  Aging (Albany NY)       Date:  2012-12       Impact factor: 5.682

Review 7.  Contribution of the Local RAS to Hematopoietic Function: A Novel Therapeutic Target.

Authors:  Kathleen E Rodgers; Gere S Dizerega
Journal:  Front Endocrinol (Lausanne)       Date:  2013-10-23       Impact factor: 5.555

8.  Local Renin-Angiotensin system in normal hematopoietic and multiple myeloma-related progenitor cells.

Authors:  Burak Uz; Suzin Çatal Tatonyan; Müge Sayitoğlu; Yücel Erbilgin; Ozden Hatırnaz; Salih Aksu; Yahya Büyükaşık; Nilgün Sayınalp; Hakan Göker; Osman İ Ozcebe; Uğur Ozbek; Ibrahim C Haznedaroğlu
Journal:  Turk J Haematol       Date:  2014-06-10       Impact factor: 1.831

Review 9.  Moonlighting Activity of Secreted Inflammation-Regulatory Proteins.

Authors:  Joo Heon Yoon; Junsun Ryu; Seung Joon Baek
Journal:  Yonsei Med J       Date:  2018-06       Impact factor: 2.759

Review 10.  Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy.

Authors:  Matthias Pinter; Rakesh K Jain
Journal:  Sci Transl Med       Date:  2017-10-04       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.